Want to see TSE:TELO full AI Analyst Report?
Telo Genomics Corp (TELO) Stock Statistics & Valuation Metrics
Total Valuation
Telo Genomics Corp has a market cap or net worth of CAD 5.02M. The enterprise value is CAD 5.86M.
- Market Cap
- CAD 5.02M
- Enterprise Value
- CAD 5.86M
Share Statistics
Telo Genomics Corp has 100,430,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 100,430,470
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Telo Genomics Corp’s return on equity (ROE) is 1.46 and return on invested capital (ROIC) is 1560.71%.
- Return on Equity (ROE)
- 1.46
- Return on Assets (ROA)
- -3.85
- Return on Invested Capital (ROIC)
- 1560.71%
- Return on Capital Employed (ROCE)
- 1.42
- Revenue Per Employee
- 0
- Profits Per Employee
- -288.84K
- Employee Count
- 8
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Telo Genomics Corp is -2.17. Telo Genomics Corp’s PEG ratio is -0.02.
- PE Ratio
- -2.17
- PS Ratio
- 0.00
- PB Ratio
- -3.17
- Price to FCF
- -3.12
- Price to Operating Cash Flow
- -3.16
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, Telo Genomics Corp had revenue of 0 and earned -2.31M in profits. Earnings per share was -0.02.
- Revenue
- 0
- Gross Profit
- -86.56K
- Operating Income
- -2.19M
- Pretax Income
- -2.33M
- Net Income
- -2.31M
- EBITDA
- -2.10M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -1.59M and capital expenditures -18,756, giving a free cash flow of -1.61M billion.
- Operating Cash Flow
- -1.59M
- Free Cash Flow
- -1.61M
- Free Cash Flow per Share
- -0.02
Dividends & Yields
Telo Genomics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -32.05%
- Earnings Yield
- -46.02%
Stock Price Statistics
- Beta
- 1.10
- 52-Week Price Change
- -9.09%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.05
- Relative Strength Index (RSI)
- 46.03
- Average Volume (3m)
- 92.47K
Important Dates
Telo Genomics Corp upcoming earnings date is Nov 19, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Nov 19, 2026
- Ex-Dividend Date
- ―
Financial Position
Telo Genomics Corp as a current ratio of 0.21, with Debt / Equity ratio of -91.20%
- Current Ratio
- 0.21
- Quick Ratio
- 0.21
- Debt to Market Cap
- 0.35
- Net Debt to EBITDA
- -0.53
- Interest Coverage Ratio
- -11.44
Taxes
In the past 12 months, Telo Genomics Corp has paid -15.38K in taxes.
- Income Tax
- -15.38K
- Effective Tax Rate
- 0.01
Enterprise Valuation
Telo Genomics Corp EV to EBITDA ratio is -2.91, with an EV/FCF ratio of -3.81.
- EV to Sales
- 0.00
- EV to EBITDA
- -2.91
- EV to Free Cash Flow
- -3.81
- EV to Operating Cash Flow
- -3.85
Balance Sheet
Telo Genomics Corp has CAD 338.32K in cash and marketable securities with CAD 1.44M in debt, giving a net cash position of -CAD 1.11M billion.
- Cash & Marketable Securities
- CAD 338.32K
- Total Debt
- CAD 1.44M
- Net Cash
- -CAD 1.11M
- Net Cash Per Share
- -CAD 0.01
- Tangible Book Value Per Share
- -CAD 0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Telo Genomics Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 25.57%
Scores
- Smart Score
- ―
- AI Score
- 46